Akebia Therapeutics, Inc. Human Resources Contracts & Agreements

54 Contracts & Agreements

Browse by Subcategory

Bonus & Incentive Agreements (23 contracts)
Compensation Agreements (6)
Consulting Agreements (2)
Employment Agreements (5)
Non-Competition Agreements (1)
Retention Agreements (10)
Separation Agreements (4)
Severance Agreements (3)

Recent Contracts

Separation Agreement (Filed With SEC on May 9, 2024)
February 2024 Amendment to Retention and Separation Agreement for Michel Dahan (Filed With SEC on March 14, 2024)
February 2024 Amendment to Retention and Separation Agreement for Nicole R. Hadas (Filed With SEC on March 14, 2024)
Form of Officer Restricted Stock Unit Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy) (Filed With SEC on March 14, 2024)
Form of Officer Stock Option Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy) (Filed With SEC on March 14, 2024)
Form of Officer Cash Bonus Agreement (Reflecting Clawback Policy) (Filed With SEC on March 14, 2024)
Form of Officer Executive Severance Agreement (Reflecting Clawback Policy) (Filed With SEC on March 14, 2024)
Third Amended and Restated Non-Employee Director Compensation Program, effective January 1, 2024 (Filed With SEC on March 14, 2024)
October 2023 Amendment to Retention and Separation Agreement for Nicole R. Hadas (Filed With SEC on November 8, 2023)
Form of Officer Inducement Award Stock Option Agreement under 2023 Stock Incentive Plan (Filed With SEC on August 28, 2023)
Form of Officer Restricted Stock Unit Agreement under 2023 Stock Incentive Plan (Filed With SEC on August 28, 2023)
Form of Non-Employee Director Restricted Stock Unit Agreement under 2023 Stock Incentive Plan (Filed With SEC on August 28, 2023)
Form of Officer Stock Option Agreement under 2023 Stock Incentive Plan (Filed With SEC on August 28, 2023)
Form of Non-Employee Director Stock Option Agreement under 2023 Stock Incentive Plan (Filed With SEC on August 28, 2023)
Second Amended and Restated Non-Employee Director Compensation Program, effective June 6, 2023 (Filed With SEC on August 28, 2023)
Separation Agreement with David Spellman, dated June 9, 2023 and Amendment to Separation Agreement dated July 6, 2023 (Filed With SEC on August 28, 2023)
July 2023 Amendment to Retention and Separation Agreement for Nicole R. Hadas (Filed With SEC on August 28, 2023)
July 2023 Amendment to Retention and Separation Agreement for Michel Dahan (Filed With SEC on August 28, 2023)
Form of May 2023 Amendment to Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas (Filed With SEC on August 28, 2023)
Form of Amendment to Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas (Filed With SEC on November 3, 2022)
Form of Officer Non-Statutory Stock Option Agreement under 2014 Incentive Plan (Filed With SEC on August 4, 2022)
Retention Agreement with David Spellman, dated June 22, 2022 (Filed With SEC on August 4, 2022)
Separation Agreement with Dell Faulkingham, dated May 5, 2022 (Filed With SEC on May 9, 2022)
Form of Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas (Filed With SEC on May 9, 2022)
Form of Officer Retention Letter Agreement (Filed With SEC on May 9, 2022)
Amended and Restated Cash Incentive Plan, effective January 19, 2022 (Filed With SEC on March 1, 2022)
Form of Officer Cash Bonus Letter Agreement (Filed With SEC on November 4, 2021)
Form of Officer Performance-Based Restricted Stock Unit Award, under the Company's 2014 Incentive Plan, as amended (Filed With SEC on November 4, 2021)
Form of Officer Performance-Based Stock Option Award, under the Company's 2014 Incentive Plan, as amended (Filed With SEC on November 4, 2021)
Non-Employee Director Compensation Program, effective January (Filed With SEC on February 25, 2021)
Consulting Agreement (Filed With SEC on November 5, 2020)
Master Consulting Services Agreement, dated as of June 10, 2019, by and between Akebia Therapeutics, Inc. and Scott A. Canute (Filed With SEC on August 8, 2019)
Form of Employee Agreement (Confidentiality, Non-Competition, Non-Solicitation and Development Agreement) applicable to officers (Filed With SEC on March 26, 2019)
Amended and Restated Non-Employee Director Compensation Program, effective January 30, 2019 (Filed With SEC on March 26, 2019)
Form of Officer Restricted Stock Unit Award Agreement under 2014 Incentive Plan (Filed With SEC on March 26, 2019)
Form of Restricted Stock Unit Award Agreement under 2014 Incentive Plan (Filed With SEC on March 12, 2018)
Non-Employee Director Compensation Program (Filed With SEC on March 12, 2018)
Restricted Stock Unit Award granted under the AKEBIA THERAPEUTICS, INC. 2014 Incentive Plan Restricted Stock Unit Award Agreement (Filed With SEC on March 4, 2015)
AKEBIA THERAPEUTICS, INC. CASH INCENTIVE PLAN (Filed With SEC on March 4, 2014)
AKEBIA THERAPEUTICS, INC. 2014 INCENTIVE PLAN (Filed With SEC on March 4, 2014)